Common regimen is hazardous for idiopathic pulmonary fibrosis
10:15 EDT 21 May 2012 | Advanstar News Headlines
NEW YORK (Reuters Health) - Treating idiopathic pulmonary fibrosis (IPF) with a combination of prednisone, azathioprine and N-acetylcysteine may increase patients' risk of death and hospitalization, doctors reported Sunday.
Original Article: Common regimen is hazardous for idiopathic pulmonary fibrosis
More From BioPortfolio on "Common regimen is hazardous for idiopathic pulmonary fibrosis"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
